vs

Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and Neptune Insurance Holdings Inc. (NP). Click either name above to swap in a different company.

Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $37.8M, roughly 1.9× Neptune Insurance Holdings Inc.). On growth, Neptune Insurance Holdings Inc. posted the faster year-over-year revenue change (28.8% vs -3.2%).

Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.

Neptune Insurance Holdings Inc. is a specialty insurance holding company that offers a broad portfolio of property and casualty insurance products, with a core focus on residential and commercial flood insurance for customers across the United States. It serves both individual consumers and small to mid-sized business clients, using advanced data analytics to support accurate policy pricing and robust risk management.

FLGT vs NP — Head-to-Head

Bigger by revenue
FLGT
FLGT
1.9× larger
FLGT
$71.1M
$37.8M
NP
Growing faster (revenue YoY)
NP
NP
+31.9% gap
NP
28.8%
-3.2%
FLGT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FLGT
FLGT
NP
NP
Revenue
$71.1M
$37.8M
Net Profit
$50.0K
Gross Margin
30.2%
Operating Margin
21.1%
Net Margin
0.1%
Revenue YoY
-3.2%
28.8%
Net Profit YoY
0.0%
EPS (diluted)
$0.04
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLGT
FLGT
NP
NP
Q1 26
$71.1M
$37.8M
Q4 25
$83.3M
Q3 25
$84.1M
$44.4M
Q2 25
$81.8M
Q1 25
$73.5M
Q4 24
$76.2M
Q3 24
$71.7M
$33.8M
Q2 24
$71.0M
Net Profit
FLGT
FLGT
NP
NP
Q1 26
$50.0K
Q4 25
$-23.4M
Q3 25
$-6.6M
$11.5M
Q2 25
$-19.0M
Q1 25
$-11.5M
Q4 24
$-5.9M
Q3 24
$-14.6M
$12.1M
Q2 24
$-8.7M
Gross Margin
FLGT
FLGT
NP
NP
Q1 26
30.2%
Q4 25
39.1%
Q3 25
42.2%
Q2 25
42.1%
Q1 25
38.6%
Q4 24
41.8%
Q3 24
37.3%
Q2 24
37.3%
Operating Margin
FLGT
FLGT
NP
NP
Q1 26
21.1%
Q4 25
-43.5%
Q3 25
-18.3%
46.7%
Q2 25
-24.1%
Q1 25
-26.9%
Q4 24
-21.2%
Q3 24
-23.8%
58.6%
Q2 24
-26.6%
Net Margin
FLGT
FLGT
NP
NP
Q1 26
0.1%
Q4 25
-28.1%
Q3 25
-7.9%
25.9%
Q2 25
-23.2%
Q1 25
-15.7%
Q4 24
-7.7%
Q3 24
-20.4%
35.8%
Q2 24
-12.3%
EPS (diluted)
FLGT
FLGT
NP
NP
Q1 26
$0.04
$0.05
Q4 25
Q3 25
$0.06
Q2 25
Q1 25
Q4 24
Q3 24
$0.06
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLGT
FLGT
NP
NP
Cash + ST InvestmentsLiquidity on hand
$23.4M
Total DebtLower is stronger
Stockholders' EquityBook value
Total Assets
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLGT
FLGT
NP
NP
Q1 26
$23.4M
Q4 25
$50.2M
Q3 25
$117.6M
$12.2M
Q2 25
$87.9M
Q1 25
$67.3M
Q4 24
$55.1M
Q3 24
$58.0M
Q2 24
$65.1M
Total Debt
FLGT
FLGT
NP
NP
Q1 26
Q4 25
Q3 25
$247.6M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
FLGT
FLGT
NP
NP
Q1 26
Q4 25
$1.1B
Q3 25
$1.1B
$-509.5M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
$-374.3M
Q2 24
$1.1B
Total Assets
FLGT
FLGT
NP
NP
Q1 26
$1.2B
Q4 25
$1.2B
Q3 25
$1.2B
$89.6M
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons